Trial reportBMJ open2019
Depressive symptoms in people with vision impairment: a cross-sectional study to identify who is most at risk.
Trial report in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Depression and Anxiety in Patients With Irreversible Vision Loss: Meta-Analysis and Systematic Review.International journal of psychiatry in medicine · 2026Pooled it
- Physical activity and visual difficulties in 36 low- and middle-income countries.Eye (London, England) · 2022Pooled it
- Association Between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis.JAMA ophthalmology · 2021Pooled it
- Growth, development, and health status of primary school students in Binzhou city: an analysis based on health examination data for 6-12-Year-olds.Frontiers in public health · 2026Article
- Trends in the prevalence and burden of blindness and vision loss among adolescents aged 10-24 years in the Western Pacific Region over 30 years.BMC public health · 2024Article
- Personality traits and symptoms of anxiety and depression in patients with primary vitreous floaters.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024Article
- The multiple mediating effects of vision-specific factors and depression on the association between visual impairment severity and fatigue: a path analysis study.BMC psychiatry · 2024Article
- Feasibility and potential effectiveness of the IdentifEYE training programmes to address mental health problems in adults with vision impairment.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2024Article
- Regional differences in the effects of healthy aging on depressive symptoms: a Korean longitudinal study of aging (2006-2020).Frontiers in public health · 2024Article
- Self-Reported Vision Impairment and Psychological Distress in U.S. Adults.Ophthalmic epidemiology · 2022Article
- Article
- Visual impairment and depression: Age-specific prevalence, associations with vision loss, and relation to life satisfaction.World journal of psychiatry · 2020Article
- Social interactions, experiences with adverse life events and depressive symptoms in individuals with visual impairment: a cross-sectional study.BMC psychiatry · 2020Article
- Combined Vision and Hearing Difficulties Results in Higher Levels of Depression and Chronic Anxiety: Data From a Large Sample of Spanish Adults.Frontiers in psychology · 2020Article
- Visual Impairment and Mental Health: Unmet Needs and Treatment Options.Clinical ophthalmology (Auckland, N.Z.) · 2020Review
- Associations Between Social Capital and Depressive Symptoms Among College Students in 12 Countries: Results of a Cross-National Study.Frontiers in psychology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify the risk factors for significant depressive symptoms in people with visual impairment in England and Wales to provide information on who is most at risk and to whom support services could be targeted in future.
designA cross-sectional study using baseline data from a pragmatic randomised controlled trial. SETTING AND
participants990 participants aged 18 or over attending 1 of 14 low-vision rehabilitation primary care optometry-based clinics in South Wales or two hospital clinics in London. OUTCOME MEASURE: A score of ≥6 on the Geriatric Depression Scale-15 was classed as clinically significant depressive symptoms.
resultsIn a multivariable logistic regression model, significant depressive symptoms were associated with age (adjusted OR (AOR)=0.82, 95% CI: 0.66 to 0.90, p<0.001), ethnicity (AOR non-white compared with white=1.72, 95% CI: 1.05 to 2.81, p=0.031), total number of eye conditions (AOR for two vs one condition=0.98, 95% CI: 0.67 to 1.43; three or more vs one condition=0.34, 95% CI: 0.15 to 0.75, p=0.026), self-reported health (AOR for excellent vs poor=0.01, 95% CI: 0.00 to 0.12; very good vs poor=0.06, 95% CI: 0.03 to 0.13; good vs poor=0.14, 95% CI: 0.08 to 0.24; fair vs poor=0.28, 95% CI: 0.18 to 0.46, p<0.001) and self-reported visual functioning (AOR=1.45, 95% CI: 1.31 to 1.61, p<0.001).
conclusionYounger age, a non-white ethnicity, fewer eye conditions and poorer self-reported health and visual function are risk factors for significant depressive symptoms in this population. TRIAL REGISTRATION NUMBER: ISRCTN46824140; Pre-results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.